-
Something wrong with this record ?
Quality evaluation of frozen apheresis red blood cell storage with 21-day postthaw storage in additive solution 3 and saline-adenine-glucose-mannitol: biochemical and chromium-51 recovery measures
M. Bohonek, M. Petráš, I. Turek, J. Urbanová, T. Hrádek, P. Chmátal, V. Staropražská, J. Koštířová, D. Horčičková, S. Duchková, J. Svobodová, E. Tejčková
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Adenine MeSH
- Sodium Chloride MeSH
- Citrates MeSH
- Adult MeSH
- Erythrocytes metabolism MeSH
- Phosphates MeSH
- Glucose MeSH
- Hemoglobins analysis MeSH
- Blood Preservation standards MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Chromium Radioisotopes diagnostic use MeSH
- Blood Component Removal MeSH
- Freezing MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: The Czech Republic decided to build the frozen red blood cell (RBC) bank for military contingency and civil emergency preparedness. Storage methods were validated with (51)Cr recovery measures out to 21 days postthaw. STUDY DESIGN AND METHODS: A total of 139 apheresis RBC units collected in additive solution (additive solution 3 [AS-3] or saline-adenine-glucose-mannitol [SAG-M]) were obtained from volunteers by double erythrocytapheresis; all were sterilely glycerolized, frozen, stored for at least 30 days at a minimum of -65 degrees C in collection or cryogenic bags, thawed, sterilely deglycerolized, and stored at 4 +/- 2 degrees C for up to 21 days in AS-3 or SAG-M. Units were sampled before storage and after thaw weekly. Metabolic intermediates and (51)Cr recovery measures were obtained to determine the index of therapeutic effectiveness (ITE). RESULTS: Despite losses associated with cryoconservation and eventual transfer to cryogenic bags, 3-week storage with optimum ITE was obtained with frozen storage in primary collection or cryogenic bags and postthaw storage in AS-3. Such cells would pass as acceptable in vitro hematology and biochemistry variables. CONCLUSIONS: A system for frozen RBC storage with 3-week, postthaw, liquid storage has been validated. With commercially available components and automated processing, it is capable of supporting civilian rare blood and emergency and international military combat and peacekeeping support use patterns.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025972
- 003
- CZ-PrNML
- 005
- 20121011191817.0
- 007
- ta
- 008
- 120817s2010 xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1537-2995.2009.02532.x $2 doi
- 035 __
- $a (PubMed)20051061
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bohoněk, Miloš, $d 1962- $7 xx0016394 $u Department of Haematology, Biochemistry and Blood Transfusion, Central Military Hospital Prague, Prague, Czech Republic. milos.bohonek@uvn.cz
- 245 10
- $a Quality evaluation of frozen apheresis red blood cell storage with 21-day postthaw storage in additive solution 3 and saline-adenine-glucose-mannitol: biochemical and chromium-51 recovery measures / $c M. Bohonek, M. Petráš, I. Turek, J. Urbanová, T. Hrádek, P. Chmátal, V. Staropražská, J. Koštířová, D. Horčičková, S. Duchková, J. Svobodová, E. Tejčková
- 520 9_
- $a BACKGROUND: The Czech Republic decided to build the frozen red blood cell (RBC) bank for military contingency and civil emergency preparedness. Storage methods were validated with (51)Cr recovery measures out to 21 days postthaw. STUDY DESIGN AND METHODS: A total of 139 apheresis RBC units collected in additive solution (additive solution 3 [AS-3] or saline-adenine-glucose-mannitol [SAG-M]) were obtained from volunteers by double erythrocytapheresis; all were sterilely glycerolized, frozen, stored for at least 30 days at a minimum of -65 degrees C in collection or cryogenic bags, thawed, sterilely deglycerolized, and stored at 4 +/- 2 degrees C for up to 21 days in AS-3 or SAG-M. Units were sampled before storage and after thaw weekly. Metabolic intermediates and (51)Cr recovery measures were obtained to determine the index of therapeutic effectiveness (ITE). RESULTS: Despite losses associated with cryoconservation and eventual transfer to cryogenic bags, 3-week storage with optimum ITE was obtained with frozen storage in primary collection or cryogenic bags and postthaw storage in AS-3. Such cells would pass as acceptable in vitro hematology and biochemistry variables. CONCLUSIONS: A system for frozen RBC storage with 3-week, postthaw, liquid storage has been validated. With commercially available components and automated processing, it is capable of supporting civilian rare blood and emergency and international military combat and peacekeeping support use patterns.
- 650 _2
- $a adenin $7 D000225
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a separace krevních složek $7 D001781
- 650 _2
- $a konzervace krve $x normy $7 D001793
- 650 _2
- $a radioizotopy chromu $x diagnostické užití $7 D002860
- 650 _2
- $a citráty $7 D002951
- 650 _2
- $a erytrocyty $x metabolismus $7 D004912
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zmrazování $7 D005615
- 650 _2
- $a glukosa $7 D005947
- 650 _2
- $a hemoglobiny $x analýza $7 D006454
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a fosfáty $7 D010710
- 650 _2
- $a chlorid sodný $7 D012965
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Petráš, Marek $7 xx0168100
- 700 1_
- $a Turek, Ivo, $d 1970- $7 xx0107908
- 700 1_
- $a Urbanová, Jaroslava, $d 1948- $7 xx0106328
- 700 1_
- $a Hrádek, Tomáš, $d 1957- $7 xx0106329
- 700 1_
- $a Chmátal, Petr
- 700 1_
- $a Staropražská, Věra $7 xx0141607
- 700 1_
- $a Koštířová, Jitka, $d 1956- $7 xx0107797
- 700 1_
- $a Horčičková, Dana $7 xx0107798
- 700 1_
- $a Duchková, Simona, $d 1972- $7 xx0126029
- 700 1_
- $a Svobodová, Jitka, $d 1956- $7 xx0061819
- 700 1_
- $a Tejčková, Eva $7 xx0081959
- 773 0_
- $w MED00004547 $t Transfusion $x 1537-2995 $g Roč. 50, č. 5 (2010), s. 1007-13
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20051061 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121011192025 $b ABA008
- 999 __
- $a ok $b bmc $g 948014 $s 783318
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 50 $c 5 $d 1007-13 $i 1537-2995 $m Transfusion $n Transfusion $x MED00004547
- LZP __
- $a Pubmed-20120817/10/03